Collectively, these findings imply a causal pathway of miR-320a in SSc-ILD by revealing that in normal pulmonary fibroblasts, miR-320a participated in the fibrotic process through coordinating a wide spectrum of profibrotic molecules like TGF-β and IGF1 pathway mediators. Here, TGFB1 is linked to interstitial lung disease.